Novo Nordisk World Diabetes Foundation Pledge: Inside the $200M, 10-Year Commitment
Novo Nordisk commits US$200M over 2027-2036 to the World Diabetes Foundation for care in low- and middle-income countries. The numbers, track record and strategy.
Read More
Premarin Discontinued in Canada: Pfizer Pulls Menopause Therapy, Tablets Last to Mid-2027
Pfizer will stop selling Premarin hormone therapy in Canada. The vaginal cream is gone, tablets last to about mid-2027. What changes, why, and what patients can do.
FDA National Priority Voucher Pilot Shelved: What Happens to 22 Drugs
Reuters reports the FDA has shelved its national priority voucher pilot. Here is the scorecard, who is exposed, and what HHS says.
DaVita Fresenius Lawsuit: Washington Says Doctor Noncompetes Lock In Dialysis Monopolies
Washington sued DaVita and Fresenius over noncompetes for dialysis medical directors across 80 centres. What the case alleges and what could change.
Hims & Hers FTC Lawsuit Widens as Five More States Join Health Data Case
Arizona, Florida, Nebraska, Ohio and Wisconsin joined the FTC suit accusing Hims & Hers of sharing health data with Meta and Snap and making plans hard to cancel.
Pfizer Blackstone Deal: $1.5B Bet on a Monthly Obesity Shot, Explained
Blackstone will fund up to $1.5B of Pfizer berobenatide development through 2028, repaid only if the monthly GLP-1 wins US approval. How the deal works.
WHO Food Profiling Model Targets Added Colours, Flavours and Sweeteners
WHO draft would flag packaged foods with added colours, flavours or sweeteners for labels, marketing limits or taxes. How it works, industry pushback and the Nov 27 deadline.
IMVIONIX Beovu Acquisition: Ex-Alimera Team Takes Over Novartis Eye Drug
IMVIONIX has acquired US and Canadian rights to Novartis eye drug Beovu. Who the buyers are, Beovu trial data and safety history, and what to watch.
CVS Split Explained: Aetna and Caremark Stay Together as 9,000 Stores Become CVS Pharmacy
CVS Health will separate into a healthcare solutions company and a standalone CVS Pharmacy by the first half of 2028. Who gets what, the Q3 numbers behind the move and what it means for patients and drugmakers.